Breadcrumb

MEDIA_REFRESH_DATA_PRESS_RELEASE

Media

U.S. News Room

Press Releases

News, Events, Updates, Breakthroughs

Journalists may direct questions to mediainquiries@dsi.com. Or click here for direct contact information for Daiichi Sankyo U.S. Public Affairs team

Press announcements are archived by release date, searchable by topic:

Fri May 29 00:00:00 GMT-05:00 2020
ENHERTU® Achieved a Tumor Response Rate of 45.3% in Patients with HER2 Positive Metastatic Colorectal Cancer in Phase 2 DESTINY-CRC01 Trial Download
Fri May 29 00:00:00 GMT-05:00 2020
Daiichi Sankyo Announces Clinical Research Collaboration to Evaluate DS-1062 in Combination with KEYTRUDA® (pembrolizumab) in Metastatic Non-Small Cell Lung Cancer Download
Thu May 28 00:00:00 GMT-05:00 2020
Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline Download
Mon May 25 00:00:00 GMT-05:00 2020
Daiichi Sankyo Launches ENHERTU® in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer Download
Fri May 22 00:00:00 GMT-05:00 2020
Daiichi Sankyo Initiates Clinical Trial with 5th DXd ADC, DS-6157, in Collaboration with Sarah Cannon Research Institute Download
Thu May 21 00:00:00 GMT-05:00 2020
ENHERTU® Granted Orphan Drug Designation in the U.S. for Gastric Cancer Download
Mon May 18 00:00:00 GMT-05:00 2020
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. for HER2 Mutant Metastatic Non-Small Cell Lung Cancer Download
Fri May 15 00:00:00 GMT-05:00 2020
Daiichi Sankyo to Present New Preclinical and Translational Research from DXd ADC Portfolio at AACR Virtual Annual Meeting II Download
Wed May 13 00:00:00 GMT-05:00 2020
Daiichi Sankyo to Present New Research Data Across DXd ADC Portfolio at 2020 ASCO Annual Meeting Download
Mon May 11 00:00:00 GMT-05:00 2020
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. for HER2 Positive Metastatic Gastric Cancer Download
Showing 181 - 190 of 195 results.